PEL.NS

Piramal Enterprises Limited PEL.NS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PEL.NS JBCHEPHARM.NS JBCHEPHARM.BO PPLPHARMA.BO ERIS.BO ERIS.NS IKS.NS IKS.BO SYNGENE.BO SYNGENE.NS
6M 9.10 % 2.10 % 2.24 % -12.22 % 13.42 % 13.30 % 9.08 % 9.00 % -12.73 % -12.76 %
YTD 2.70 % -9.98 % -9.87 % -23.65 % 19.10 % 19.09 % -20.20 % -20.26 % -26.93 % -27.00 %
1Y 9.61 % -11.03 % -10.86 % -8.39 % 24.27 % 24.56 % -20.97 % -21.03 % -23.50 % -23.47 %
3Y 33.43 % 70.78 % 71.11 % 21.21 % 115.10 % 115.57 % -20.97 % -21.03 % 11.67 % 11.62 %
5Y 55.43 % 64.50 % 225.45 % 5.25 % 210.94 % 217.51 % -20.97 % -21.03 % 19.62 % 19.68 %
10Y 114.64 % 468.26 % 1 039.25 % 5.25 % 163.84 % 163.59 % -20.97 % -21.03 % 243.03 % 241.77 %
From the beginning 4 306.90 % 7 309.29 % 82 858.33 % 5.25 % 163.84 % 163.59 % -20.97 % -21.03 % 313.53 % 313.38 %

Dividend

Piramal Enterprises Limited

J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited

Piramal Pharma Limited

Eris Lifesciences Limited

Eris Lifesciences Limited

Syngene International Limited

Syngene International Limited